Pheon Therapeutics
Latest round
- Series B
Last raised
- May 2024
Total raised
- $189M
Investors
- 8
About Pheon Therapeutics
, operates as a developer of antibody-drug conjugate that could help treat cancer patients. In September 2022, Pheon Therapeutics Ltd. The company offers healthcare solutions by developing antibody-drug conjugates (ADCs) that are used to treat various hard-to-treat cancers. The company is currently working on two solid tumor projects that include PHN-010, and PHN-020.
Who invested in Pheon Therapeutics
8 investors across 2 rounds
See all investors in Pheon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pheon Therapeutics
Who invested in Pheon Therapeutics?
Pheon Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pheon Therapeutics raised?
Pheon Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pheon Therapeutics last raise money?
Pheon Therapeutics's most recent round on record is a Series B, in May 2024.
What does Pheon Therapeutics do?
, operates as a developer of antibody-drug conjugate that could help treat cancer patients.
Where is Pheon Therapeutics headquartered?
Pheon Therapeutics is headquartered in London, UK.
Which VCs invest in companies like Pheon Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Pheon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pheon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.